However, as summarized in Table 2, no remarkable correlations were detected between the expression level of eIF4G1 protein and patient age, degree of differentiation, optimal or suboptimal cytoreduction, response to chemotherapy or the serum of CA-125 in patients with ovarian cancer. Here, EIF4G1 is linked to ovarian cancer.